X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (39981) 39981
Book Review (9194) 9194
Publication (1920) 1920
Newsletter (286) 286
Book Chapter (126) 126
Conference Proceeding (106) 106
Magazine Article (83) 83
Book / eBook (42) 42
Transcript (12) 12
Newspaper Article (10) 10
Dissertation (5) 5
Reference (5) 5
Trade Publication Article (5) 5
Web Resource (5) 5
Data Set (4) 4
Government Document (3) 3
Paper (3) 3
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (35903) 35903
index medicus (35375) 35375
male (20361) 20361
female (19797) 19797
immunosuppressive agents - therapeutic use (19736) 19736
immunosuppressive agents - adverse effects (18480) 18480
adult (14714) 14714
middle aged (14306) 14306
transplantation (11458) 11458
treatment outcome (8515) 8515
immunosuppressive agents - administration & dosage (7664) 7664
surgery (7241) 7241
aged (6843) 6843
immunology (6642) 6642
immunosuppressive agents (5459) 5459
adolescent (5443) 5443
risk factors (5177) 5177
animals (5108) 5108
retrospective studies (4872) 4872
time factors (4622) 4622
kidney transplantation (4355) 4355
child (4265) 4265
drug therapy, combination (4200) 4200
therapy (4145) 4145
immunosuppression (4120) 4120
cyclosporine (3990) 3990
follow-up studies (3553) 3553
tacrolimus (3473) 3473
abridged index medicus (3460) 3460
graft rejection - prevention & control (3385) 3385
cyclosporine - therapeutic use (3380) 3380
kidney transplantation - adverse effects (3346) 3346
cyclosporine - adverse effects (3314) 3314
recipients (3166) 3166
young adult (2898) 2898
pharmacology & pharmacy (2834) 2834
immunosuppressive agents - pharmacology (2824) 2824
care and treatment (2668) 2668
health aspects (2639) 2639
tacrolimus - therapeutic use (2587) 2587
mycophenolic acid - analogs & derivatives (2542) 2542
immunotherapy (2528) 2528
kidney transplantation - immunology (2426) 2426
kidneys (2423) 2423
gastroenterology & hepatology (2346) 2346
urology & nephrology (2335) 2335
tacrolimus - adverse effects (2296) 2296
prospective studies (2242) 2242
child, preschool (2220) 2220
analysis (2209) 2209
disease (2193) 2193
drug therapy (2179) 2179
hematology (2126) 2126
medicine & public health (2068) 2068
dermatology (2061) 2061
transplantation, homologous (2034) 2034
rheumatology (1997) 1997
mycophenolic acid - therapeutic use (1945) 1945
medicine, general & internal (1917) 1917
research (1870) 1870
azathioprine - therapeutic use (1849) 1849
mycophenolate-mofetil (1820) 1820
recurrence (1785) 1785
oncology (1779) 1779
pediatrics (1779) 1779
dose-response relationship, drug (1777) 1777
children (1740) 1740
antibodies, monoclonal - therapeutic use (1729) 1729
immunosuppressive agents - pharmacokinetics (1707) 1707
biopsy (1704) 1704
azathioprine (1683) 1683
graft survival (1673) 1673
incidence (1665) 1665
graft rejection - immunology (1651) 1651
liver transplantation (1650) 1650
calcineurin inhibitors (1643) 1643
prognosis (1639) 1639
cyclosporine - administration & dosage (1630) 1630
corticosteroids (1612) 1612
renal-transplantation (1592) 1592
organ transplant recipients (1556) 1556
immunocompromised host (1545) 1545
efficacy (1539) 1539
patients (1510) 1510
tacrolimus - administration & dosage (1509) 1509
risk (1487) 1487
drug administration schedule (1475) 1475
mice (1467) 1467
liver (1465) 1465
double-blind (1453) 1453
cancer (1433) 1433
azathioprine - adverse effects (1428) 1428
sirolimus (1427) 1427
transplants & implants (1427) 1427
sirolimus - therapeutic use (1415) 1415
rats (1414) 1414
infection (1399) 1399
graft rejection (1380) 1380
kidney-transplantation (1372) 1372
mycophenolate mofetil (1363) 1363
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (27) 27
Online Resources - Online (7) 7
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Gerstein Science - Periodical Stacks (1) 1
Trinity College (John W Graham) - Storage (1) 1
UTL at Downsview - May be requested (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (37148) 37148
German (841) 841
French (704) 704
Spanish (514) 514
Japanese (383) 383
Chinese (157) 157
Italian (134) 134
Russian (116) 116
Polish (100) 100
Hungarian (63) 63
Dutch (48) 48
Danish (47) 47
Portuguese (38) 38
Norwegian (35) 35
Czech (34) 34
Croatian (22) 22
Swedish (19) 19
Hebrew (17) 17
Finnish (15) 15
Korean (12) 12
Serbian (9) 9
Bulgarian (8) 8
Romanian (7) 7
Lithuanian (5) 5
Turkish (5) 5
Slovak (3) 3
Icelandic (2) 2
Bosnian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
American Journal of Gastroenterology, ISSN 0002-9270, 01/2013, Volume 108, Issue 1, pp. 99 - 105
OBJECTIVES: The risk of non-Hodgkin's lymphoma (NHL) with tumor necrosis factor alpha (TNF-alpha) inhibitors is unclear, whether related to concomitant... 
RHEUMATOID-ARTHRITIS | INFLAMMATORY-BOWEL-DISEASE | THERAPY | AZATHIOPRINE | RISK | INFLIXIMAB | GASTROENTEROLOGY & HEPATOLOGY | CANCER | MEDLINE | Azathioprine - therapeutic use | Lymphoma, T-Cell - chemically induced | Certolizumab Pegol | United States | Humans | Immunoglobulin Fab Fragments - adverse effects | Immunosuppressive Agents - therapeutic use | Middle Aged | Antibodies, Monoclonal - adverse effects | Polyethylene Glycols - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Immunoglobulin Fab Fragments - therapeutic use | Polyethylene Glycols - therapeutic use | Receptors, Tumor Necrosis Factor - therapeutic use | Etanercept | Infliximab | Arthritis, Rheumatoid - drug therapy | Mercaptopurine - therapeutic use | Aged, 80 and over | Adult | Female | Drug Therapy, Combination | Odds Ratio | United States Food and Drug Administration | Inflammatory Bowel Diseases - drug therapy | Antibodies, Monoclonal, Humanized - adverse effects | SEER Program | Antibodies, Monoclonal, Humanized - therapeutic use | Psoriasis - drug therapy | Adverse Drug Reaction Reporting Systems | Risk Factors | Spondylitis, Ankylosing - drug therapy | Mercaptopurine - adverse effects | Immunoglobulin G - therapeutic use | Immunoglobulin G - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Immunosuppressive Agents - adverse effects | Aged | Adalimumab | Azathioprine - adverse effects | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2011, Volume 365, Issue 20, pp. 1886 - 1895
Journal Article
Lancet, The, ISSN 0140-6736, 11/2012, Volume 380, Issue 9856, pp. 1829 - 1839
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2013, Volume 19, Issue 1, pp. 117 - 122
Abstract Fifty patients with high-risk hematologic malignancies, underwent an unmanipulated haploidentical bone marrow transplantation (BMT), followed by... 
Hematology, Oncology and Palliative Medicine | Haploidentical transplantations | Acute leukemia | HLA | Posttransplantation cyclophosphamide | Allogeneic stem cell transplant | MORTALITY | IMMUNOLOGY | RECIPIENTS | VERSUS-HOST-DISEASE | TRANSPLANTATION | REDUCED-INTENSITY | ACUTE-LEUKEMIA | HIGH-RISK | HAPLOTYPE | OUTCOMES | STEM-CELL TRANSPLANTATION | HEMATOLOGY | BLOOD | Hematologic Neoplasms - therapy | Whole-Body Irradiation | Cyclophosphamide - administration & dosage | Follow-Up Studies | Myeloablative Agonists - adverse effects | Thiotepa - administration & dosage | Hematologic Neoplasms - mortality | Humans | Middle Aged | Male | Antineoplastic Agents - administration & dosage | Busulfan - administration & dosage | Cyclophosphamide - adverse effects | Transplantation, Homologous | Graft vs Host Disease - mortality | Antineoplastic Agents - adverse effects | Bone Marrow Transplantation | Adult | Female | Retrospective Studies | Graft vs Host Disease - etiology | Immunosuppressive Agents - administration & dosage | Acute Disease | Busulfan - adverse effects | Vidarabine - adverse effects | Survival Rate | Vidarabine - analogs & derivatives | Disease-Free Survival | Adolescent | Myeloablative Agonists - administration & dosage | Graft vs Host Disease - prevention & control | Immunosuppressive Agents - adverse effects | Aged | Vidarabine - administration & dosage | Transplantation Conditioning | Chronic Disease | Thiotepa - adverse effects | Antimitotic agents | Pneumonia | Cyclophosphamide | Bacterial pneumonia | Mortality | Bone marrow | Transplantation | Antineoplastic agents | Cancer | Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2013, Volume 369, Issue 5, pp. 417 - 427
This study of ANCA-associated vasculitis compared a single course of rituximab with conventional immunosuppression with cyclophosphamide followed by... 
WEGENERS-GRANULOMATOSIS | MAINTENANCE | MEDICINE, GENERAL & INTERNAL | ANTIBODY-ASSOCIATED VASCULITIS | RENAL VASCULITIS | CYCLOPHOSPHAMIDE | RITUXIMAB | ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES | RANDOMIZED-TRIAL | SYSTEMIC VASCULITIDES | CELL-ACTIVATION | Recurrence | Azathioprine - therapeutic use | Glucocorticoids - therapeutic use | Double-Blind Method | Drug Administration Schedule | Humans | Immunosuppressive Agents - therapeutic use | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Immunologic Factors - administration & dosage | Kaplan-Meier Estimate | B-Lymphocytes | Rituximab | Cyclophosphamide - adverse effects | Remission Induction | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - drug therapy | Cyclophosphamide - therapeutic use | Immunosuppressive Agents - adverse effects | Immunologic Factors - adverse effects | Drug Therapy, Combination | Antibodies, Monoclonal, Murine-Derived - adverse effects | Azathioprine - adverse effects | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Immunologic Factors - therapeutic use | Immunosuppression | Vasculitis | Drug therapy | Patient outcomes | Disease | Medical treatment | Hypersensitivity | Patients | Immunosuppressive agents | Cyclophosphamide | Infectious diseases | Lymphocytes B | Antineutrophil cytoplasmic antibodies | Remission | Azathioprine | Index Medicus | Abridged Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2014, Volume 371, Issue 4, pp. 326 - 338
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2015, Volume 373, Issue 15, pp. 1418 - 1428
Journal Article